Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Range Finding Study of Fedovapagon in Men With Nocturia

This study has been completed.
Information provided by (Responsible Party):
Vantia Ltd Identifier:
First received: July 31, 2012
Last updated: June 18, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 18, 2014